Patient Activation Through Community Empowerment/Engagement for Diabetes Management (PACE-D)

NCT04288362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1620

Last updated 2022-04-26

No results posted yet for this study

Summary

The study is a non-randomised controlled trial involving an intervention group and a control group. It aims to evaluate the effects of a patient engagement and empowerment model of collaborative care support planning on clinical outcomes of patients with diabetes mellitus as compared to usual care in the primary care setting. It also aims will be to examine the impact of the intervention on patient activation, patient and healthcare provider experience, and healthcare utilisation.

Conditions

Interventions

OTHER

Intervention Group

Participants in this arm will undergo the new care model for management of diabetes mellitus polyclinics.

OTHER

Control Group

Participants in this arm will continue to undergo the existing care model for management of diabetes mellitus in the polyclinics.

Sponsors & Collaborators

  • National University Hospital, Singapore

    collaborator OTHER
  • National University of Singapore

    collaborator OTHER
  • National University Health System, Singapore

    lead OTHER

Principal Investigators

  • Doris Young · National University Health System, Singapore

  • Victor Weng Keong Loh · National University Health System, Singapore

  • Tong Wei Yew · National University Hospital, Singapore

  • Kavita Venkataraman · National University of Singapore

  • Brent Gibbons · National University of Singapore

  • Vikki Entwistle · National University of Singapore

  • Soon Guan Tan · National University of Singapore

  • Meena Sundram · National University Health System, Singapore

  • Keith Tsou · National University Health System, Singapore

  • Yii Jen Lew · National University Health System, Singapore

  • Wee Hian Tan · National University Health System, Singapore

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-25
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04288362 on ClinicalTrials.gov